PRF Technologies Ltd. (PRFX )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol PRFX
- Company PRF Technologies Ltd.
- Price $1.61
- Changes Percentage 14.18
- Change 0.2
- Day Low $1.46
- Day High $2.28
- Year High $17.95
- Year Low $1.28
- Market Cap $149,790
- Price Avg 50 EMA (D) $2.08
- Price Avg 200 EMA (D) $4.31
- Exchange NASDAQ
- Volume 404,205
- Average Volume 1,853,864
- Open $1.6
- Previous Close $1.41
- EPS -7.47
- PE -0.25
- Earnings Announcement 2026-04-06 04:00:00
- Shares Outstanding $80,532
Company brief: PRF TECHNOLOGIES LTD. (PRFX )
- Healthcare
- Drug Manufacturers - Specialty & Generic
- Mr. Ilan Hadar M.B.A.
- https://www.painreform.com
- IL
- N/A
- 09-01-2020
- IL0011651580
PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company is currently conducting two Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. PainReform Ltd. was incorporated in 2007 and is based in Tel Aviv, Israel.